Pharmaceutically active compositions comprising oxidative stress modulators (OSM), new chemical entities, compositions and uses
AU2011239432A1
Androgen induced oxidative stress inhibitors
US2011091931A1
Methods and Kits for Determining Oxygen Free Radical (OFR) Levels in Animal and Human Tissues as a Prognostic Marker for Cancer and Other Pathophysiologies
SG175251A1
Pharmaceutically active compositions comprising oxidative stress modulators (osm), new chemical entities, compositions and uses
WO2008109740A2
Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers
